|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.5 USD | -1.54% |
|
-2.30% | -24.42% |
On March 24, 2022, Spine BioPharma, LLC closed the transaction. The company has issued 2,141,680 shares for gross proceeds of $12,999,998 in the transaction. The transaction including participation from existing investors, Viscogliosi Brothers LLC, Cercano Management LLC, Pacira BioSciences, Inc. and others.
The company has received $12,999,991 in pursuant to exemption provided under Regulation D from 6 investors. The round is raised at a post money valuation of $62,401,087.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.42% | 1.2B | |
| +24.17% | 562B | |
| -6.33% | 358B | |
| +19.90% | 322B | |
| +7.95% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -12.26% | 149B | |
| -6.47% | 146B |
PACIRA BIOSCIENCES, INC. 
